First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1 -receptor partial agonist for the treatment of dementias. - Bakker C; Tasker T; Liptrot J; Hart EP; Klaassen ES; Prins S; van der Doef TF; Brown GA; Brown A; Congreve M; Weir M; Marshall FH; et al. (British journal of clinical pharmacology, 2021)